Tag: Pharma Analyst
Japan’s homegrown COVID-19 mRNA vaccine needs superior safety & efficacy data...
In 2021, leading mRNA vaccines, Comirnaty and Spikevax, generated combined sales of more than $54 billion globally and are expected to generate similar or greater sales in 2022